home *** CD-ROM | disk | FTP | other *** search
/ Cancer - Principles & Practice of Oncology / Oncology.iso / PPO / CHAP45 / T5_1.GIF < prev    next >
Graphics Interchange Format  |  1999-06-07  |  151.7 KB  |  749x318  |  8-bit (240 colors)
   ocr: TABLE 45.5-1. Clinical and Pathologic Features of Myelodysplastic Syndromes5.1620.49 Survival () Bone MDS Progression Marrow (% of Cases) toAML (%) Range Median LOW-RISK MDS Refractory anemia <5% blasts 15-30 10 1-5 4 Refractory anemia with ringed sideroblasts <5% blasts* 10-15 10 1-5 4 HIGH-RISK MDS Refractory anemia wich excess of blasts 5-19% blasts 25-30 45 0.5-2 Refractory anemia with excess of blasts in transformation 20-29% 20 60 <I 0.5 CHRONIC MYELOMONOCYTIC LEUKEMIA <20%t 10-20 15 1-5 ACUTE MYELOID LEUKEMIA WITH HISTORY OF MDS 230% blasts NA NA <I 0.5 NA, not applicable; MDS, myelodys ...